Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Jun 28, 2023
- Accession no.
- 0001209191-23-040105
- Filed
- Jun 28, 2023
- Trade date
- Jun 26-28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $788.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | Common Stock | MOption exerciseAcquired | +17,232 | $0.61 | +$10,511.52 | 545,213 | Direct | |
| Jun 26, 2023 | Common Stock | SSaleDisposed | −10,862 | $16.49F2 | −$179,114.38 | 534,351 | Direct | |
| Jun 26, 2023 | Common Stock | SSaleDisposed | −6,370 | $17.24F3 | −$109,818.8 | 527,981 | Direct | |
| Jun 27, 2023 | Common Stock | MOption exerciseAcquired | +16,028 | $0.61 | +$9,777.08 | 544,009 | Direct | |
| Jun 27, 2023 | Common Stock | SSaleDisposed | −7,893 | $16.73F4 | −$132,049.89 | 536,116 | Direct | |
| Jun 27, 2023 | Common Stock | SSaleDisposed | −8,135 | $17.09F5 | −$139,027.15 | 527,981 | Direct | |
| Jun 28, 2023 | Common Stock | MOption exerciseAcquired | +13,524 | $0.61 | +$8,249.64 | 541,505 | Direct | |
| Jun 28, 2023 | Common Stock | SSaleDisposed | −13,524 | $16.91F6 | −$228,690.84 | 527,981 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | Common Stock | MOption exerciseDisposed | −17,232 | $0.00 | $0 | 211,830 | Direct | |
| Jun 27, 2023 | Common Stock | MOption exerciseDisposed | −16,028 | $0.00 | $0 | 195,802 | Direct | |
| Jun 28, 2023 | Common Stock | MOption exerciseDisposed | −13,524 | $0.00 | $0 | 182,278 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.005. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.69. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.01 to $17.01. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.20. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.50 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.